Lower Antibodies Rate in Cancer Patients After Symptomatic COVID-19 Than In Healthcare Workers
Antibodies more often undetectable in patients who received anticancer treatment in the month prior to testing
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
Antibodies more often undetectable in patients who received anticancer treatment in the month prior to testing
Application concerned first-line treatment in patients with NSCLC and PD-L1 scores between 1 and 49%
This new product allows for subcutaneous dosing of daratumumab
Findings from 16 centres worldwide
FDA also approved a companion diagnostic for capmatinib
Balancing pandemic control with providing continued cancer care
It is indicated in combination with cetuximab for the treatment of adult patients with metastatic colorectal cancer with a BRAF V600E mutation
An FDA-approved companion diagnostic is not required to initiate treatment with niraparib for this indication
With Manuela Eicher, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Glasdegib, an Hedgehog inhibitor, is intended for the treatment of acute myeloid leukaemia
Accelerated approval is based on data from the Cohort B of Study KEYNOTE-555
Pathology analysis found enrichment of fusions after progression on endocrine therapy
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.